Carret Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.47M Sell
78,723
-2,448
-3% -$283K 0.93% 26
2025
Q4
$8.54M Sell
81,171
-770
-0.9% -$72.3K 0.81% 31
2025
Q3
$6.88M Buy
81,941
+259
+0.3% +$21.3K 0.67% 40
2025
Q2
$6.47M Sell
81,682
-431
-0.5% -$34.3K 0.69% 42
2025
Q1
$7.37M Buy
82,113
+1,463
+2% +$137K 0.83% 30
2024
Q4
$8.02M Buy
80,650
+374
+0.5% +$38.6K 0.88% 29
2024
Q3
$9.12M Buy
80,276
+1,170
+1% +$139K 0.99% 22
2024
Q2
$9.79M Sell
79,106
-542
-0.7% -$69.8K 1.14% 15
2024
Q1
$10.5M Sell
79,648
-2,480
-3% -$306K 1.24% 15
2023
Q4
$8.95M Sell
82,128
-727
-0.9% -$75.5K 1.14% 15
2023
Q3
$8.53M Sell
82,855
-448
-0.5% -$48.3K 1.19% 14
2023
Q2
$9.61M Sell
83,303
-1,452
-2% -$165K 1.27% 14
2023
Q1
$9.02M Sell
84,755
-5,672
-6% -$612K 1.25% 16
2022
Q4
$10M Buy
90,427
+900
+1% +$92K 1.39% 14
2022
Q3
$7.71M Sell
89,527
-1,028
-1% -$91.8K 1.15% 16
2022
Q2
$8.26M Buy
90,555
+88
+0.1% +$7.8K 1.15% 17
2022
Q1
$7.42M Buy
90,467
+330
+0.4% +$26K 0.85% 27
2021
Q4
$6.91M Buy
90,137
+2,230
+3% +$178K 0.76% 30
2021
Q3
$6.6M Buy
87,907
+259
+0.3% +$19.7K 0.79% 28
2021
Q2
$6.82M Buy
87,648
+1,969
+2% +$146K 0.8% 27
2021
Q1
$6.3M Buy
85,679
+2,393
+3% +$177K 0.78% 34
2020
Q4
$6.5M Buy
83,286
+1,078
+1% +$82.4K 0.88% 25
2020
Q3
$6.51M Buy
82,208
+241
+0.3% +$18.9K 0.98% 26
2020
Q2
$6.05M Buy
81,967
+560
+0.7% +$42.2K 0.98% 22
2020
Q1
$5.98M Sell
81,407
-3,123
-4% -$245K 1.15% 20
2019
Q4
$7.34M Buy
84,530
+1,374
+2% +$113K 1.07% 19
2019
Q3
$6.68M Sell
83,156
-744
-0.9% -$59.6K 1.06% 23
2019
Q2
$6.71M Buy
83,900
+345
+0.4% +$26.4K 1.07% 20
2019
Q1
$6.63M Sell
83,555
-1,108
-1% -$82.9K 1.08% 19
2018
Q4
$6.17M Sell
84,663
-450
-0.5% -$31.8K 1.11% 20
2018
Q3
$5.76M Sell
85,113
-1,209
-1% -$77K 0.89% 27
2018
Q2
$5M Buy
86,322
+382
+0.4% +$21.6K 0.82% 33
2018
Q1
$4.47M Buy
85,940
+856
+1% +$46.2K 0.74% 42
2017
Q4
$4.57M Buy
85,084
+2,022
+2% +$112K 0.71% 43
2017
Q3
$5.08M Buy
83,062
+386
+0.5% +$23.4K 0.82% 36
2017
Q2
$5.06M Buy
82,676
+5,880
+8% +$358K 0.85% 34
2017
Q1
$4.66M Buy
76,796
+1,925
+3% +$117K 0.84% 34
2016
Q4
$4.21M Buy
74,871
+1,337
+2% +$78.2K 0.8% 36
2016
Q3
$4.38M Sell
73,534
-314
-0.4% -$18.4K 0.82% 38
2016
Q2
$4.06M Buy
73,848
+4,485
+6% +$239K 0.78% 40
2016
Q1
$3.5M Buy
69,363
+4,815
+7% +$236K 0.74% 44
2015
Q4
$3.25M Buy
64,548
+370
+0.6% +$18.7K 0.69% 49
2015
Q3
$3.02M Buy
64,178
+9,705
+18% +$516K 0.66% 48
2015
Q2
$2.96M Buy
54,473
+13,776
+34% +$773K 0.59% 54
2015
Q1
$2.23M Sell
40,697
-121
-0.3% -$6.85K 0.43% 64
2014
Q4
$2.21M Buy
40,818
+3,076
+8% +$171K 0.42% 71
2014
Q3
$2.13M Sell
37,742
-309
-0.8% -$17.4K 0.41% 71
2014
Q2
$2.1M Sell
38,051
-200
-0.5% -$10.9K 0.4% 73
2014
Q1
$2.07M Sell
38,251
-908
-2% -$47K 0.41% 72
2013
Q4
$1.87M Buy
39,159
+116
+0.3% +$5.3K 0.38% 73
2013
Q3
$1.77M Buy
39,043
+7,136
+22% +$326K 0.39% 72
2013
Q2
$1.41M Buy
+31,907
New +$1.43M 0.29% 86

Other funds holding MRK

Carret Asset Management's MRK Position: Q1 2026 in Review

Carret Asset Management reduced its Merck (MRK) stake by 3% in Q1 2026, selling an estimated $283K and leaving 78,723 shares worth $9.47M. The position accounts for 0.93% of the portfolio, ranked #26.

Carret Asset Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.5M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Carret Asset Management held 78,723 shares of Merck worth $9.47M as of Q1 2026.
  • Carret Asset Management sold 2,448 Merck shares in Q1 2026, an estimated $283K.
  • Merck made up 0.93% of Carret Asset Management's portfolio in Q1 2026, its #26 holding.
  • Carret Asset Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Carret Asset Management's Merck position peaked at $10.5M in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Carret Asset Management's 13F filing for Q1 2026, filed 15 May 2026.